Scarica l'app Stockscreener
143.24
1.21%
-1.76
Dopo l'orario di chiusura:
144.10
0.86
+0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina director Keith Meister sells $47.9m in shares - Investing.com
Illumina(ILMN.US) Director Sells US$47.93 Million in Common Stock - Moomoo
Corvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan
RBC Capital assumes Illumina stock coverage with outperform rating - Investing.com
[SCHEDULE 13G/A] ILLUMINA, INC. Amended Passive Investment Disclosure - Stock Titan
Illumina stock (US4523271090): Shares up 10.6% YTD amid strong earnings beat - AD HOC NEWS
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.
Here Are Thursday’s Top Wall Street Analyst Research Calls: Commercial Metals, Doximity, Draftkings, Hut 8, Illumina, Lowe’s, TeraWulf, Starbucks, Whirlpool, Wix.com, and More - Yahoo Finance
Daiwa Securities Upgrades Illumina to Outperform From Neutral, Adjusts Price Target to $155 From $128 - marketscreener.com
Bioinformatics Platforms Market Is Going to Boom | • Illumina Inc • Thermo Fisher Scientific Inc • QIAGEN N.V - openPR.com
ILMN Stock Analysis 2026: Should You Invest in Illumina Now? - sebd.in
Number of shareholders of Illumina, Inc. – SIX:ILMN - TradingView
Illumina (ILMN) Form 144 lists 600,000 shares with Goldman Sachs broker - Stock Titan
Illumina stock (US4523271090): Q1 2026 earnings beat signals recovery momentum - AD HOC NEWS
Illumina stock (US4523271090): Consensus Hold rating reflects steady biotech positioning - AD HOC NEWS
The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major BuybackLearn Why - simplywall.st
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina stock (US4523271090): Analyst consensus shifts to Hold amid mixed signals - AD HOC NEWS
Illumina Inc. stock (US4523271090): Latest developments and business overview - AD HOC NEWS
SomaLogic stock (US82489T1043): Completed $350M sale to Illumina - AD HOC NEWS
Illumina Innovation Fund Iii, L.p. Net Worth (2026) - GuruFocus
How Illumina employees work to move healthcare toward precision medicine - Illumina
Corvex funds (NASDAQ: ILMN) exercise Illumina equity swaps, retain large position - Stock Titan
The future of global food security may depend on quality agrigenomics software - Illumina
NovaSeq X software update v1.4 improves data quality and customer usability - Illumina
Illumina stock (US4523271090): Q1 earnings beat lifts shares 8% YTD - AD HOC NEWS
We Think That There Are Issues Underlying Illumina's (NASDAQ:ILMN) Earnings - simplywall.st
Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Frontier with Strong Revenue Growth and Strategic Partnerships - DirectorsTalk Interviews
Avoiding Lag: Real-Time Signals in (ILMN) Movement - Stock Traders Daily
HPE, Charles Schwab, Zomedica, Illumina, Circle Insider Shake-Up - TipRanks
Illumina Inc. stock (US4523271090): Earnings beat and momentum lift shares - AD HOC NEWS
Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades' - MSN
Dna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com
Illumina Inc. Stock (US4523271090): Analyst Ratings and Price Targets in Focus - AD HOC NEWS
Illumina SVP Jakob Wedel Christensen sells $97,328 in stock - Investing.com UK
Illumina SVP Jakob Wedel Christensen sells $97,328 in stock By Investing.com - Investing.com Australia
Illumina (NASDAQ: ILMN) SVP logs 700-share sale and 233-share tax withholding - Stock Titan
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina Patent Lawsuit Targets BillionToOne Prenatal Tests (1) - Bloomberg Law News
Illumina showcases multi-omics potential to advance precision medicine in India - Indian Pharma Post
Next-Generation Genome Mapping Market is Thriving Worldwide | - openPR.com
Microfluidics Market Competitive Analysis to 2031 | Illumina, Inc, microfluidic ChipShop GmbH, Danaher etc. - openPR.com
Illumina Shareholder Action Reminder - TMX Newsfile
[144] ILLUMINA, INC. SEC Filing - Stock Titan
Whole Exome Sequencing Market key players 2024-2031: Illumina, Inc., Centogene AG, Eurofins Scientific etc - openPR.com
Assessing Illumina (ILMN) Valuation After Earnings Beat Guidance Hike And Expanded Buyback - Yahoo Finance
Illumina Shareholder Alert - TMX Newsfile
Here's Why Illumina (ILMN) is a Strong Growth Stock - Yahoo Finance
Epigenetics Market is expected to Hit US$ 7.10 Billion by 2033 | - openPR.com
Illumina, Inc. Q1 2026 Financial Report: Earnings, Revenue, Risk Factors & Forward-Looking Statements 18 24 37 - Minichart
Final Trades: Uber, Exxon, Illumina and Diamondback Energy - CNBC
Illumina Partners with Florida State University Lab for Rare Disease Genome Sequencing - Clinical Lab Products
Genomics Market size is anticipated to reach US$ 83.61 billion - openPR.com
Illumina, Inc. (ILMN) Stock Analysis: Exploring Its 33.82% Return On Equity - DirectorsTalk Interviews
Illumina (ILMN) Q1 2026 Earnings: Revenue Beat and Raised GuidanceNews and Statistics - IndexBox
Illumina, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ILMN) 2026-05-03 - Seeking Alpha
ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges - Yahoo Finance
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), Moderna (MRNA) and Dexcom (DXCM) - The Globe and Mail
Illumina revenue up 4.8% to USD 1.09B in Q1 2026 - Medical Buyer
Jennison Associates LLC Has $26.21 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
1.60%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):